This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages without signing in

Zyban (R)

Authoring team

  • Zyban is the slow-release form of the antidepressant bupropion - it is the first antidepressant licensed for smoking cessation
  • unlike nicotine replacement therapy, treatment is started two weeks before quitting smoking
  • one hypothesis suggests that Zyban might work in smoking cessation by increasing levels of noradrenaline and dopamine in the brain. This therefore counteracts the reductions in these neurochemicals that results from nicotine withdrawal

The summary of product characteristics should be consulted before prescribing this drug.

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.